Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pyridam Farma Tbk (PYFA) vs Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap (XIML) Price & Performance

Pyridam Farma TbkTrade
Reksa Dana Indeks Premier ETF MSCI Indonesia Large CapTrade

Price performance (Past 24H)

Key statistics

Pyridam Farma Tbk vs Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap — how do they compare? Pyridam Farma Tbk trades at Rp210 (market cap 2.43T, 2.13M 24h volume), while Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap trades at Rp189 (market cap 32.38B). The key difference: Pyridam Farma Tbk is far larger — about 75× Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap's market cap. Which is the better fit depends on your goals.

PYFAXIML
Market Cap
2.43T32.38B
Volume
2.13M
Lot
21.26K
Turnover
449.54M
Average Price
211.5
Value
449.54M
Indicative Equilibrium Price
214
Indicative Equilibrium Volume
1.54K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PYFA
View details

About Pyridam Farma Tbk

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Read more on PYFA

About Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap

Read more on XIML